Search

DENVER, May 13, 2010 – A new study based on a large cohort of patients proves strategic programming of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-D) reduces shocks. The results are part of a shock reduction late-breaking clinical trial presented today at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions. According to the trial, strategic programming results in overall shock reduction between 17 and 28 percent depending on the programming of specific variables.

DENVER, May 13, 2010 – According to a new study released today at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions, remote monitoring proves effective for earlier detection of arrhythmic events and pacemaker dysfunction in elderly patients with atrial fibrillation (AF). The study is the first to consider using remote monitoring on elderly patients to detect and treat AF compared to standard follow-up procedures.

DENVER, May 13, 2010 – Common herbal and nonherbal supplements, such as garlic, ginkgo and essential fatty acids, contribute to an increased risk of health complications in patients treated with warfarin. According to a new study released today at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions, eight out of the top ten supplements commonly taken by American consumers have been reported to impact the effectiveness of warfarin and overall safety of the individual.

DENVER, May 13, 2010 – African Americans have a significantly lower incidence of postoperative atrial fibrillation (AF) compared to Caucasians despite a higher prevalence of risk factors for this specific type of arrhythmia. According to a new study presented today at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions, Caucasians are 60 percent more likely than African Americans to develop AF following heart surgery.

DENVER, May 13, 2010 – According to a sub-study of the Multicenter Automatic Defibrillator Implantation Trial-CRT (MADIT-CRT), females receive a clinically significant benefit from cardiac resynchronization therapy devices (CRT-D) compared to men. New research presented today at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions, indicates that CRT-D therapy reduces all-cause mortality and heart failure (HF) and death end point in females, but not in males.

DENVER, May 14, 2010 – The Heart Rhythm Society (HRS) has released the first consensus statement for the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting device deactivation. The HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy was written in collaboration with representatives from the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Heart Association (AHA) and the European Heart Rhythm Association (EHRA). 

WASHINGTON, June 1, 2010 — New study findings prove continuing warfarin therapy during pacemaker or defibrillator implantation in patients with moderate to high thromboembolic risk is safe and cost-effective. According to research published in the June edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, cessation of warfarin with bridging anticoagulation resulted in a higher incidence of bleeding complications and a longer hospital stay.  In addition, patients with temporarily interrupted anticoagulation suffered from a higher risk of transient ischemic attacks (TIA) than those who continued warfarin therapy.

WASHINGTON, July 1, 2010 — New large meta-analysis from five primary prevention randomized implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of Sudden Cardiac Death (SCD) on overall mortality in women.  According to research published in the July edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, women in primary prevention ICD trials have the same overall mortality as men, while experiencing significantly less appropriate ICD interventions. With more than 1,600 women, this meta-analysis includes the largest cohort of women to date.  

WASHINGTON, August 31, 2010 — Released today, a new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals as a result of shifting demographic trends, evolving health reform policies and improved procedural outcomes. The comprehensive workforce study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, found substantial growth in the overall volume and complexity of cardiac procedures performed in the past decade.